You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Concordia Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CONCORDIA, and what generic and branded alternatives to CONCORDIA drugs are available?

CONCORDIA has fifteen approved drugs.

Summary for Concordia

US Patents:	0
Tradenames:	16
Ingredients:	14
NDAs:	15

Drugs and US Patents for Concordia

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Concordia	UROXATRAL	alfuzosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021287-001	Jun 12, 2003	AB	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Concordia	PLAQUENIL	hydroxychloroquine sulfate	TABLET;ORAL	009768-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Concordia	PANRETIN	alitretinoin	GEL;TOPICAL	020886-001	Feb 2, 1999		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Concordia	NILANDRON	nilutamide	TABLET;ORAL	020169-001	Sep 19, 1996		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Concordia	SALAGEN	pilocarpine hydrochloride	TABLET;ORAL	020237-002	Apr 18, 2003	AB	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Concordia	DUTOPROL	hydrochlorothiazide; metoprolol succinate	TABLET, EXTENDED RELEASE;ORAL	021956-001	Aug 28, 2006		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Concordia Pharms Inc	JENLOGA	clonidine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022331-002	May 25, 2010		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Concordia

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Concordia Pharms Inc	KAPVAY	clonidine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022331-004	Sep 28, 2010	5,869,100	⤷ Try a Trial
Concordia Pharms Inc	JENLOGA	clonidine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	022331-002	May 25, 2010	5,869,100	⤷ Try a Trial
Concordia	PANRETIN	alitretinoin	GEL;TOPICAL	020886-001	Feb 2, 1999	7,056,954	⤷ Try a Trial
Concordia Pharms Inc	ORAPRED ODT	prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING;ORAL	021959-002	Jun 1, 2006	6,024,981	⤷ Try a Trial
Concordia	UROXATRAL	alfuzosin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021287-001	Jun 12, 2003	4,661,491*PED	⤷ Try a Trial
Concordia	ZONEGRAN	zonisamide	CAPSULE;ORAL	020789-001	Mar 27, 2000	6,342,515	⤷ Try a Trial
Concordia Pharms Inc	ORAPRED ODT	prednisolone sodium phosphate	TABLET, ORALLY DISINTEGRATING;ORAL	021959-003	Jun 1, 2006	6,221,392	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for CONCORDIA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Tablets	0.1 mg and 0.2 mg	➤ Subscribe	2011-03-04
➤ Subscribe	Orally Disintegrating Tablets	10 mg, 15 mg and 30 mg	➤ Subscribe	2010-07-22
➤ Subscribe	Extended-release Tablets	0.1 mg and 0.2 mg	➤ Subscribe	2011-03-04
➤ Subscribe	Extended-release Tablets	10 mg	➤ Subscribe	2007-06-12

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.